A total of 197 multidose injectable vials were collected from 10 different nursing stations and evaluated for sterility. Experimental contamination studies were undertaken, and the cost-effectiveness of multidose vials was compared with that of single-dose vials. Our results showed that bacterial contamination of multidose injectable vials was not a significant hazard; in addition, contrary to common belief, the use of multidose vials was not always successful as a cost-containment measure.
The use of multidose injectable vials in hospitals continues to be promoted as a cost-containment measure for hospitals and taxpayers. While the medication is on the ward, the vial is entered into several times and presumed to remain sterile. As part of a study for the infection control program at the Veterans Administration Medical Center, Wood, Wisc., we compared the sterility and cost-effectiveness of these vials with that of single-dose vials for the same medication (5; J. A. Jacobson, J. C. Bawden, J. C. Jackson, R. K. Anderson, and J. P. Burke, Program Abstr. Intersci. Conf. Antimicrob. Agents Chemother. 21st, Chicago, Ill., abstr. no. 853.). Experimentally contaminated vials were also evaluated (6) .
We collected 197 opened injectable vials, containing 50 different medications scheduled for removal from the wards at the end of a 1-month period, from 10 different nursing stations at the Veterans Administration Medical Center. We sent them to the microbiology laboratory. with a 10-to 100-fold decrease in the number of bacteria at 96 h. Pseudomonas sp., Bacillus sp., and diphtheroids were the predominant flora surviving. The number of bacteria present on the unswabbed vials and thumb surface samples varied greatly; the average was 30 and 21 colonies per square centimeter, respectively. The colonies consisted of coagulase-negative staphylococci, diphtheroids, and a saprophytic mold.
On the basis of limited data available for this cost accounting study, the total cost of the medications purchased in 92 multidose vials was $223.77. The unit dose cost of these drugs was multiplied by the number of times the medication was used on the ward; the total cost was $120.00. Thus, a missed potential savings of 46% was obvious, with part of the problem being the low usage of multidose vials.
This study was undertaken primarily to assess the safety of using multidose vials in a hospital setting from the sterility standpoint. Several previous studies (1, 2, 4, 7-9) showed a 1 to 2.8% contamination rate of multidose vials, with two experimental studies (7, 9) showing total sterility. The results of a recent simulated contamination study in storage conditions (3) suggested that the risk of significant microbial contamination for at least some medications is low but varies with the medication. Our results showed that all 197 vials collected from the wards were sterile; the one-sided 95% confidence limit for the actual contamination was 0 to 1.51%. As part of the infection control policy for nursing at the Veterans Administration Medical Center, reconstituted vials are given a 2-week outdate. They are removed by the pharmacy service at the end of a 1-month period. Thus, multidose vials can potentially be used for a maximum of 29 days. In a setting where usage of multidose vials is low, the common generalization that use of multidose vials is a cost-containment measure is not necessarily true. We feel that hospitals should evaluate individual wards for multidose vial usage, patient turnover, and number of patients on ward on the same medication and review policies on removal of medications from the wards. Our studies indicated that there was adequate bacteriostasis in the multidose vials for patient care and, vials subjected to attempts at more importantly, experimental lowlevel contamination retained adequate sterility. 
